The Importance of Using Author ID’s

Author ids and profiles are the best way of keeping track of and promoting your research publications.  Potential funders, employers, and colleagues can learn more about your professional work and make the connection between you, your C.V., and your professional publications.

These unique numbers can help to distinguish you as an author and help to avoid misattribution of articles in databases and on research sites.   Registering for these ids can help you as an author claim all the articles written by yourself and allow you to confirm your identity and your body of scientific works.  This is important because researchers need to show the results of their projects to funders and other interested parties to satisfy the obligations of grants and to continue to find and procure future research funding.

In a digital environment owning and being able to control your professional identify is important for many reasons. 

As an author and a researcher you should actively try to distinguish yourself from your peers. If you have a common name it is even more important to make an effort to stand apart from researchers with the same name.  Author ids are a vital tool for intellectual control. It is important as an author to be able to share your publications and research on your terms.  This should be a high priority when you are working to establish a reputation in your profession.  Researchers who publish should know the importance of making sure works are attributed to the correct authors.  A properly created and complete bibliography can help you immensely as you look for new professional positions and grant funding.

As your reputation grows and your work receives more attention it is important that other researchers cite your works properly.  An author id can make sure your work is cited in a standardized form which allows better tracking in databases like Web of Science.  An author id can also improve the visibility and discoverability of you and your work which can make it easier for you to connect to potential funders, employers, and collaborators.  Properly maintained author ids can also help you improve your h index score and other author rankings.

Other benefits include time savings.  Author ids can help in filling forms, applying for grants and applications, and creating personal bibliographies.  More and more major funding resources require author ids for this reason.  Another benefit is that the id’s you acquire are permanent and stay with you for your entire career they aren’t tied to your employer, institution, or grants.  You as the author own your author ids.  You maintain, update, and manage your ids in the way that best suits your needs.

Whether you are starting your career or are a well established researcher creating and maintaining author ids can help you.  The Talbot Research Library is here to help you navigate the complex and ever growing world of online author ids.  Learn more about author ids on our subject guide all about scholarly communication.  The library can help you decide which author id is best for you, set up your ids, and help you manage them.  Call or email to discuss this service with the librarians.  

Quick Links

The New PubMed is Here!

The New PubMed Interface.

The time has come to say good bye to the very familiar and reliable PubMed interface we’ve all be using for years.  Don’t worry though a newer and improved PubMed is here to take its place.  Starting on or around May 18, 2020 the legacy PubMed interface will be retired and the new Pubmed will become the default search interface.  It may take some time to become familiar with the new look of Pubmed but once you do you will find many new and improved function that make searching and sharing even easier.

What’s new? First the new interface use a responsive design.  It works better on mobile devices of all sizes.  It has a cleaner interface for searching and a visually appealing search results screen which makes it easier to read and interact with your search results.

You’ll find a large single box to start your searching.  This leads to improved searching by allowing you to use free text searching to start your search.  That’s right no need for tags, booleans, or specialized language to get started.  You can still use all of these if you want you don’t need them to get started.

Your search results are now sorted by a best match algorithm.  That means you will find most relevant articles first.  You also get article snippets in the results list to show you where you search terms are found in the article results.

Other exciting new features include improvements to the side bars of the search results and article pages. Functions such as citation citing for multiple formats, better timeline navigation including a graphical timeline, previous and next buttons for browsing, and options to share articles via social media or with a permalink can be found on the side bars of both search results and article pages.

You’ll also see more buttons on article pages linking to full text articles. You can click on the teal button for Fox Chase subscriptions, publisher buttons, and open access option buttons if available.  

While the interface may be changing you will still have all the same classic PubMed features you rely on in a new interface.  To learn more go to the Talbot Library’s Pubmed Libguide to see the latest features, access handouts, videos, and more to get started.  If you have any questions or would like to request a training session please contact the librarians via email.

Remember to use the Talbot Library Link to PubMed to gain access to subscription full text!

Staff Publications Received in April, 2020

1.            Amer A, Whelan A, Al-Hebshi NN, Healy CM, Moran GP. Acetaldehyde production by Rothia mucilaginosa isolates from patients with oral leukoplakia. J Oral Microbiol, 12(1):1743066, 2020. PMC7170386

2.            Bevelacqua JJ, Welsh J, Mortazavi SMJ. Comment on “Salivary antimicrobial proteins and stress biomarkers are elevated during a 6-month mission to the International Space Station”. J Appl Physiol (1985), 128(4):1088-9, 2020. Letter

3.            Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. Robotic Partial Nephrectomy versus Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU Int, 2020. 

4.            Chakraborty A, Tapryal N, Venkova T, Mitra J, Vasquez V, Sarker AH, Duarte-Silva S, Huai WH, Ashizawa T, Ghosh G, Maciel P, Sarkar PS, Hegde ML, Chen X, Hazra TK. Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis. Proceedings of the National Academy of Sciences of the United States of America, 117(14):8154-65, 2020. 

5.            Chen VE, Greenberger BA, Taylor JM, Edelman MJ, Lu B. The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review. Int J Radiat Oncol Biol Phys, 2020. 

6.            Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Netw, 18(4):380-91, 2020. 

7.            Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat, 2020. PMC7181102

8.            Drevik J, Abbosh P. Novel Biomarkers in Chromophobe Renal Cell Carcinoma: Distinguishing it from its Mimics. Eur Urol, 2020. Editorial

9.            Dunlevy KL, Medvedeva V, Wilson JE, Hoque M, Pellegrin T, Maynard A, Kremp MM, Wasserman JS, Poleshko A, Katz RA. The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting. J Cell Sci, 2020. 

10.          Edelman MJ. Population-Based Outcomes in NSCLC. JNCI Cancer Spectr, 3(3):pkz022, 2019. PMC7050018

11.          Endo M, Nabhan F, Angell TE, Harrell M, Nasr C, Wei S, Sipos JA. Use of Molecular Diagnostic Tests in Thyroid Nodules with Hurthle Cell-Dominant Cytology. Thyroid, 2020. 

12.          Galsky MD, Mortazavi A, Milowsky MI, George S, Gupta S, Fleming MT, Dang LH, Geynisman DM, Walling R, Alter RS, Kassar M, Wang J, Gupta S, Davis N, Picus J, Philips G, Quinn DI, Haines GK, 3rd, Hahn NM, Zhao Q, Yu M, Pal SK. Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer. J Clin Oncol:Jco1903091, 2020. 

13.          Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE): Results of a Phase II Trial. J Urol:101097ju0000000000001065, 2020. 

14.          Ghiraldi EM, Braitman LE, Friedlander JI. Factors associated with compliance with 24-hour urine collection. Urology, 2020. 

15.          Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Krishnamurthy J, Lyons J, Marcom PK, Matro J, Mayer IA, Moran MS, Mortimer J, O’Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Young JS, Burns JL, Kumar R. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(4):452-78, 2020. 

16.          Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone Ii CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol, 2020. 

17.          Hoppenot C, Schuitevoerder D, Izquierdo FJ, Plana A, Pothuri B, Yamada SD, Kim J, Lee NK, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-Kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Bowne WB, Brown CK, Catenacci DV, Chan CHF, Chapel DB, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Grotz TE, Gushchin V, Hanna N, Harmath C, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, Johnston FM, Jiang D, Iii JMK, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Kluger MD, Lastra RR, Lee B, Mack LA, Maduekwe UN, Mak GZ, Mammen JMV, Mathew MS, Melis M, Melnitchouk N, Merkow RP, Mogal H, Moller MG, Moroney J, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Royal R, Salti G, Sardi A, Senthil M, Setia N, Sherman SK, Sideris L, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga KK. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. Cancer. 

18.          Izquierdo FJ, Plana A, Schuitevoerder D, Hayes-Jordan A, Deneve JL, Al-Kasspooles M, Bowne WB, Brown CK, Kane JM, Kelly KJ, Kennedy TJ, Maduekwe UN, Mak GZ, Melis M, Royal R, Abbott DE, Abdel-Misih S, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Husain AN, Idrees K, Ihemelandu C, Jiang D, Johnston FM, Lowy AM, Karakousis G, Keutgen XM, Kindler HL, Kluger MD, Lee B, Mack LA, Mammen JMV, Mathew MS, Melnitchouk N, Merkow RP, Mogal H, Moller MG, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Salti G, Sardi A, Senthil M, Setia N, Sideris L, Sherman SK, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga KK, Chicago Consensus Working G. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Cancer. 

19.          Judd J, Borghaei H. Combining Immunotherapy and Chemotherapy for Non-Small Cell Lung Cancer. Thorac Surg Clin, 30(2):199-206, 2020. 

20.          Kaplon AW, Galloway TJ, Bhayani MK, Liu JC. Effect of HPV Status on Survival of Oropharynx Cancer with Distant Metastasis. Otolaryngology-Head and Neck Surgery. 

21.          Karakasheva TA, Kijima T, Shimonosono M, Maekawa H, Sahu V, Gabre JT, Cruz-Acuna R, Giroux V, Sangwan V, Whelan KA, Natsugoe S, Yoon AJ, Philipone E, Klein-Szanto AJ, Ginsberg GG, Falk GW, Abrams JA, Que J, Basu D, Ferri L, Diehl JA, Bass AJ, Wang TC, Rustgi AK, Nakagawa H. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids. Curr Protoc Stem Cell Biol, 53(1):e109, 2020. 

22.          Khowsathit J, Bazzoli A, Cheng H, Karanicolas J. Computational Design of an Allosteric Antibody Switch by Deletion and Rescue of a Complex Structural Constellation. ACS Cent Sci, 6(3):390-403, 2020. PMC7099597 submitted a provisional patent describing the Rip-3/Stitch-3 system.

23.          Kowalski LP, Sanabria A, Ridge JA, Ng WT, de Bree R, Rinaldo A, Takes RP, Makitie AA, Carvalho AL, Bradford CR, Paleri V, Hartl DM, Vander Poorten V, Nixon IJ, Piazza C, Lacy PD, Rodrigo JP, Guntinas-Lichius O, Mendenhall WM, D’Cruz A, Lee AWM, Ferlito A. COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck, 2020. 

24.          Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol, 203(4):684-9, 2020. 

25.          Li HY, Terry MB, Antoniou AC, Phillips KA, Kast K, Mooij TM, Engel C, Nogues C, Stoppa-Lyonnet D, Lasset C, Berthet P, Mari V, Caron O, Barrowdale D, Frost D, Brewer C, Evans DG, Izatt L, Side L, Walker L, Tischkowitz M, Rogers MT, Porteous ME, Snape K, Meijers-Heijboer HEJ, Gille JJP, Blok MJ, Hoogerbrugge N, Daly MB, Andrulis IL, Buys SS, John EM, McLachlan SA, Friedlander M, Tan YY, Osorio A, Caldes T, Jakubowska A, Simard J, Singer CF, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Arver B, Olsson H, Schmutzler RK, Hopper JL, Milne RL, Easton DF, Van Leeuwen FE, Rookus MA, Andrieu N, Goldgar DE, Study G, Study E, Investigators H, Investigators KC. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium. Cancer Epidemiology Biomarkers & Prevention, 29(2):368-78, 2020. 

26.          Liu JRC, Kaplon A, Blackman E, Miyamoto C, Savior D, Ragin C. The impact of the multidisciplinary tumor board on head and neck cancer outcomes. Laryngoscope, 130(4):946-50, 2020. 

27.          Maclean JC, Halpern MT, Hill SC, Pesko MF. The effect of Medicaid expansion on prescriptions for breast cancer hormonal therapy medications. Health Serv Res, 2020. 

28.          Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol, 203(4):690-8, 2020. 

29.          Merryman RW, Carreau NA, Advani RH, Spinner MA, Herrera AF, Chen R, Tomassetti S, Ramchandren R, Hamid M, Assouline S, Santiago R, Wagner-Johnston N, Paul S, Svoboda J, Bair SM, Barta SK, Liu Y, Nathan S, Karmali R, Burkart M, Torka P, David KA, Wei C, Lansigan F, Emery L, Persky D, Smith SM, Godfrey J, Chavez J, Cohen JB, Troxel AB, Diefenbach C, Armand P. Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma. Oncologist, 2020. 

30.          Mookerjee-Basu J, Hooper R, Gross S, Schultz B, Go CK, Samakai E, Ladner J, Nicolas E, Tian YY, Zhou B, Zaidi MR, Tourtellotte W, He S, Zhang Y, Kappes DJ, Soboloff J. Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo. Embo Reports. 

31.          Muench DE, Olsson A, Ferchen K, Pham G, Serafin RA, Chutipongtanate S, Dwivedi P, Song BB, Hay S, Chetal K, Trump-Durbin LR, Mookerjee-Basu J, Zhang KJ, Yu JNC, Lutzko C, Myers KC, Nazor KL, Greis KD, Kappes DJ, Way SS, Salomonis N, Grimes HL. Mouse models of neutropenia reveal progenitor-stage-specific defects. Nature. 

32.          Nilov D, Maluchenko N, Kurgina T, Pushkarev S, Lys A, Kutuzov M, Gerasimova N, Feofanov A, Svedas V, Lavrik O, Studitsky VM. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine. Int J Mol Sci, 21(6), 2020. PMC7139824

33.          Pal T, Agnese D, Daly M, La Spada A, Litton J, Wick M, Klugman S, Esplin ED, Jarvik GP, Professional Practice G. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 22(4):681-5, 2020. 

34.          Pinheiro PS, Medina H, Callahan KE, Kwon D, Ragin C, Sherman R, Kobetz EN, Jemal A. Cancer mortality among US blacks: Variability between African Americans, Afro-Caribbeans, and Africans. Cancer Epidemiol, 66:101709, 2020. 

35.          Plana A, Izquierdo FJ, Schuitevoerder D, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-Kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Bowne WB, Blazer DG, Brown CK, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Hart J, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, In H, Johnston FM, Jiang D, Kane JM, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Kluger MD, Lee B, Mack LA, Maduekwe UN, Mak GZ, Mammen JMV, Mathew MS, Melis M, Melnitchouk N, Merkow RP, Micic D, Mogal H, Moller MG, Nash GM, Oto A, Pameijer CR, Parsad S, Patel P, Polite BN, Pappas SG, Polanco PM, Reddy SS, Royal R, Salti G, Sardi A, Setia N, Senthil M, Sherman SK, Sideris L, Skitzki J, Snyder BS, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga KK, Chicago Consensus Working G. The Chicago Consensus on peritoneal surface malignancies: Standards. Cancer. 

36.          Post SJ, Keohane CE, Rossiter LM, Kaplan AR, Khowsathit J, Matuska K, Karanicolas J, Wuest WM. Target-Based Design of Promysalin Analogues Identifies a New Putative Binding Cleft in Succinate Dehydrogenase. ACS Infect Dis, 2020. 

37.          Prado LG, Arruda HS, Peixoto Araujo NM, de Oliveira Braga LE, Banzato TP, Pereira GA, Figueiredo MC, Ruiz ALTG, Eberlin MN, de Carvalho JE, Vendramini-Costa DB, Pastore GM. Antioxidant, antiproliferative and healing properties of araticum (Annona crassiflora Mart.) peel and seed. Food Research International, 133, 2020. 

38.          Reese JB, Sorice KA, Zimmaro LA, Lepore SJ, Beach MC. Communication about Sexual Health in Breast Cancer: What Can We Learn from Patients’ Self-Report and Clinic Dialogue? Patient Educ Couns, 2020. 

39.          Ruggeri JM, Franco-Barraza J, Sohail A, Zhang Y, Long D, Pasca di Magliano M, Cukierman E, Fridman R, Crawford HC. Discoidin Domain Receptor 1 (DDR1) is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma. Am J Pathol, 2020. 

40.          Sawyer TW, Koevary JW, Howard CC, Austin OJ, Rice PFS, Hutchens GV, Chambers SK, Connolly DC, Barton JK. Fluorescence and Multiphoton Imaging for Tissue Characterization of a Model of Postmenopausal Ovarian Cancer. Lasers Surg Med, 2020. 

41.          Schuitevoerder D, Izquierdo FJ, Plana A, Nash GM, Fernandez LJ, Kluger MD, Mack LA, Mammen JMV, Pameijer CR, Polanco PM, Sideris L, Skitzki J, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-Kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Bowne WB, Brown CK, Catenacci DV, Chan CHF, Chandler CS, Chapel DB, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, In H, Jiang D, Johnston FM, Kane JM, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Lee B, Maduekwe UN, Mak GZ, Melis M, Melnitchouk N, Mathew MS, Merkow RP, Mogal H, Moller MG, Oto A, Pappas SG, Polite BN, Reddy SS, Royal R, Salti G, Sardi A, Senthil M, Setia N, Sherman SK, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga KK, Chicago Consensus Working G. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 

42.          Strathearn LS, Stepanov AI, Font-Burgada J. Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. Nutrients, 12(4), 2020. 

43.          Uzzo RN, Bloom E, Peters A, Parab M, Masic S, Kutikov A. Refractory hypertension due to unilateral renal lymphangiectasia: An uncommon case with a surgical solution. Urol Case Rep, 32:101177, 2020. PMC7171455

44.          Van Cleemput J, Poelaert K, Laval K, Vanderheijden N, Dhaenens M, Daled S, Boyen F, Pasmans F, Nauwynck HJ. An Alphaherpesvirus Exploits Antimicrobial beta-Defensins To Initiate Respiratory Tract Infection. Journal of Virology, 94(8), 2020. 

45.          von Mehren M, George S, Heinrich MC, Schuetze SM, Yap JT, Yu JQ, Abbott A, Litwin S, Crowley J, Belinsky M, Janeway KA, Hornick JL, Flieder DB, Chugh R, Rink L, Van den Abbeele AD. Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study. Clinical Cancer Research, 26(8):1837-45, 2020. 

46.          Wallis SL, Emmett EA, Hardy R, Casper BB, Blanchon DJ, Testa JR, Menges CW, Gonneau C, Jerolmack DJ, Seiphoori A, Steinhorn G, Berry TA. Challenging Global Waste Management – Bioremediation to Detoxify Asbestos. Frontiers in Environmental Science, 8, 2020. 

47.          Wang M, Munoz J, Goy A, Locke FL, Jacobson CA, Hill BT, Timmerman JM, Holmes H, Jaglowski S, Flinn IW, McSweeney PA, Miklos DB, Pagel JM, Kersten MJ, Milpied N, Fung H, Topp MS, Houot R, Beitinjaneh A, Peng W, Zheng L, Rossi JM, Jain RK, Rao AV, Reagan PM. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. N Engl J Med, 382(14):1331-42, 2020. 

48.          Webster MR, Fane ME, Alicea GM, Basu S, Kossenkov AV, Marino GE, Douglass SM, Kaur A, Ecker BL, Gnanapradeepan K, Ndoye A, Kugel C, Valiga A, Palmer J, Liu Q, Xu X, Morris J, Yin X, Wu H, Xu W, Zheng C, Karakousis GC, Amaravadi RK, Mitchell TC, Almeida FV, Xiao M, Rebecca VW, Wang YJ, Schuchter LM, Herlyn M, Murphy ME, Weeraratna AT. Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. Mol Cell, 77(3):633-44.e5, 2020. 

49.          Wei W, Lin Y, Song Z, Xiao W, Chen L, Yin J, Zhou Y, Barta SK, Petrus M, Waldmann TA, Yang Y. A20 and RBX1 regulate brentuximab vedotin sensitivity in Hodgkin Lymphoma models. Clin Cancer Res, 2020. 

50.          Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Futterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology:190646, 2020. 

51.          Wilson SK, Simhan J, Gross MS. Cylinder insertion into scarred corporal bodies: prosthetic urology’s most difficult challenge: some suggestions for making the surgery easier. Int J Impot Res, 2020. 

52.          Wilson SK, Simhan J, Osmonov D. Should occasional implanters learn ectopic placement of IPP reservoirs? Int J Impot Res, 2020. 

53.          Wong JK, Shaikh T, DeMora L, Zhang E, Borghaei H, Hayes SB, Kumar S, Meyer JE, Hallman MA. Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials, 43(4):243-8, 2020. 

54.          Wu X, Gardashova G, Lan L, Han S, Zhong C, Marquez RT, Wei L, Wood S, Roy S, Gowthaman R, Karanicolas J, Gao FP, Dixon DA, Welch DR, Li L, Ji M, Aube J, Xu L. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Commun Biol, 3(1):193, 2020. PMC7181695

55.          Zare A, Mortazavi SMJ. The Efficacy of Periodic Complete Blood Count Tests in Evaluation of the Health Status of Radiation Workers in Iran: A Systematic Review. Iranian Journal of Public Health, 49(4):628-36, 2020. 

56.          Zimmaro LA, Lepore SJ, Beach MC, Reese JB. Patients’ perceived barriers to discussing sexual health with breast cancer healthcare providers. Psychooncology, 2020. 


Working from home can be challenging but we want you to know that we are here for you.  The Talbot Research Library and its highly skilled librarians are here to help you with you research no matter where you are.  If you need help with research questions, literature searches, finding articles, navigating databases, or figuring out how to use library resources from home we can help.  You may not be able to drop in the library to talk with us right now but we are still just as eager to help you with your projects.

You can email the library staff anytime at or use the library’s website to request articles and searches.  The website also gives you access to subscription databases and our collection of online journals and books.  Use the search box on the homepage search the print collection (and make lists for a future visit).  We are also offering a contactless self check out option to patrons who are on campus and need a book or two.  Instructions are on the computer in the reading room.  

We are also renewing all currently checked out books so don’t worry about returning books or overdue notices.  Just let us know you need a renewal and we’ll take care of it!  If you do want to return a book just put it in the book drop outside the library.

Need Media Services?  Learn more about things like virtual meetings and other audiovisual needs on their webpage.

The library’s homepage is also the best place to access our subject guides including our informative Covid-19 guide.  We have 32 informative guides to help you learn more about a variety of subjects such as Evidence Based Medicine, Endnote, and Scholarly Publications.  

Here is a handy list for you to help you use the library’s resources:

  • Article requests and literature searches use the links in the Quick Links box 
  • Reference assistance or troubleshooting email us

The library’s blog Talbot Topics is a great resource for you as well.  Learn about new resources, services, and much more right here on the blog. 

Follow us on Twitter for the latest updates about the library.

We can’t be together in the library but we can still support each other.  Please feel free to reach out to the librarians at the Talbot Library anytime!  We look forward to hearing from you!

Libkey Nomad – What it is and what it does.

The Talbot Research Library is excited to announce that we have a new library resource available for our patrons.  Users of the Google Chrome web browser can take advantage of a new Chrome Extension called Libkey Nomad from the company that created Browzine, Third Iron.  This extension will integrate the Talbot Library’s electronic resource holdings into Pubmed, Google Scholar, Wikipedia and more.  This means you will get easy and direct access to full articles in these products with a single click.  It accesses both the journals subscribed to by the library and open access journals.  This research tool will make finding articles easier and more efficient.  You will have access to full text articles in a variety of places while searching using the Chrome browser.

In Pubmed will be able to see full text options in the search results without having to select an abstract.  You’ll also be able to easily request via interlibrary loan material not held by the Talbot Library. In Google Scholar you will see a button alerting you to full text options available after you select a citation.  In Wikipedia you will have access to full text articles directly from entry references.  All of these enhancements will save you valuable research time.

Libkey Nomad is not only a wonderful research tool it is also a way to protect your online privacy.  Use of the Chrome extension requires no additional personal accounts and doesn’t cache any personal information.  

Libkey Nomad is easy to set up and works seamlessly with the library’s proxy server.  You will still need to log into your Fox Chase account to get full access to pdf files of articles but now you can do it with less clicking and frustration.  To get Libkey Nomad follow the directions below:

  1. Add the extension to your browser from the Google Chrome Store
  2. Select Fox Chase Cancer Center from the Select Institution List.
  3. When you use your browser to search Pubmed, Google Scholar, Wikipedia, or access a journal website directly you will see a new blue button with the green tear drop.  This is your access option button

Right now this extension is only available for Google Chrome but a mobile version is in the works so stay tuned.   

If you haven’t tried Browzine yet it’s also a useful tool provided to you from the Talbot Library.  Itps perfect for keeping current on your professional reading on the go.  It allows you to access the library’s electronic journals from your phone or tablet.  This app is easy to install.  To learn more click here.

If you have any questions or need help installing the extension please feel free to contact the library at any time.  (


Staff Publications Received in March, 2020.

1.            Abou-Alfa G.K., Sahai V., Hollebecque A., Vaccaro G., Melisi D., Al-Rajabi R., Paulson A.S., Borad M.J., Gallinson D., Murphy A.G., Oh D.Y., Dotan E., Catenacci D.V., Van Cutsem E., Ji T., Lihou C.F., Zhen H., Feliz L.,Vogel A., Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: A multicentre, open-label, phase 2 study. Lancet Oncol, 2020. 

2.            Agarwal A., Dayal A., Kircher S.M., Chen R.C.,Royce T.J., Analysis of price transparency via national cancer institute-designated cancer centers’ chargemasters for prostate cancer radiation therapy. JAMA Oncology. 6(3): 409-412, 2020. 

3.            Avkshtol V., Ruth K.J., Ross E.A., Hallman M.A., Greenberg R.E., Price R.A., Jr., Leachman B., Uzzo R.G., Ma C., Chen D., Geynisman D.M., Sobczak M.L., Zhang E., Wong J.K., Pollack A.,Horwitz E.M., Ten-year update of a randomized, prospective trial of conventional fractionated versus moderate hypofractionated radiation therapy for localized prostate cancer. J Clin Oncol: Jco1901485, 2020. 

4.            Bai T., Egleston B.L., Bleicher R.,Vucetic S., Medical concept representation learning from multi-source data. Ijcai (u s). 2019: 4897-4903, 2019.PMC7047512.

5.            Baraniya D., Chen T., Nahar A., Alakwaa F., Hill J., Tellez M., Ismail A., Puri S.,Al-Hebshi N.N., Supragingival mycobiome and inter-kingdom interactions in dental caries. J Oral Microbiol. 12(1): 1729305, 2020.PMC7048226.

6.            Beauchemin L., Slifker M., Rossell D.,Font-Burgada J., Characterizing mhc-i genotype predictive power for oncogenic mutation probability in cancer patients. Methods Mol Biol. 2131: 185-198, 2020. 

7.            Bevelacqua J.J., Welsh J.,Mortazavi S.M.J., Comments on “association of telomere length with chronic exposure to ionizing radiation among inhabitants of natural high background radiation areas of ramsar, iran”. Int J Radiat Biol: 1-2, 2020. 

8.            Cannon A.C., Uribe-Alvarez C.,Chernoff J., Rac1 as a therapeutic target in malignant melanoma. Trends in Cancer, 2020. 

9.            Chandrashekar P., Ahmadinejad N., Wang J., Sekulic A., Egan J.B., Asmann Y.W., Kumar S., Maley C.,Liu L., Somatic selection distinguishes oncogenes and tumor suppressor genes. Bioinformatics. 36(6): 1712-1717, 2020. 

10.          Clapper M.L.,Fang C.Y., Honoring paul f. Engstrom, md: A pioneer of cancer prevention. Cancer Prev Res (Phila). 13(3): 215-218, 2020. 

11.          Clapper M.L., Chang W.L.,Cooper H.S., Dysplastic aberrant crypt foci: Biomarkers of early colorectal neoplasia and response to preventive intervention. Cancer Prev Res (Phila). 13(3): 229-240, 2020.PMC7080315.

12.          Collins B.N., Nair U.S., Davis S.M.,Rodriguez D., Increasing home smoking restrictions boosts underserved moms’ bioverified quit success. Am J Health Behav. 43(1): 50-56, 2019. 

13.          Correa A.F., Ruth K.J., Al-Saleem T., Pei J., Dulaimi E., Kister D., Collins M., Abbosh P.H., Slifker M.J., Ross E., Uzzo R.G.,Testa J.R., Overall tumor genomic instability: An important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma. Cancer Biol Ther. 21(5): 424-431, 2020. 

14.          Correani V., Martire S., Mignogna G., Caruso L.B., Tempera I., Giorgi A., Grieco M., Mosca L., Schinina M.E., Maras B.,d’Erme M., Poly(adp-ribosylated) proteins in beta-amyloid peptide-stimulated microglial cells. Biochem Pharmacol. 167: 50-57, 2019. 

15.          Daly M.B., Navigating the intersection between genomic research and clinical practice. Cancer Prev Res (Phila). 13(3): 219-222, 2020.PMC7080295.

16.          Dawson N.A., Zibelman M., Lindsay T., Feldman R.A., Saul M., Gatalica Z., Korn W.M.,Heath E.I., An emerging landscape for canonical and actionable molecular alterations in primary and metastatic prostate cancer. Mol Cancer Ther, 2020. 

17.          Devlin A., Gonzalez E., Ramsey F., Esnaola N.,Fisher S., The effect of discrimination on likelihood of participation in a clinical trial. J Racial Ethn Health Disparities, 2020. 

18.          Edelman M.J., New therapies in special populations. JCO Oncol Pract: Op2000082, 2020. 

19.          Engel R.M., Silver C.C., Veeder C.L.,Banks R.E., Cognitive dissonance in laboratory animal medicine and implications for animal welfare. Journal of the American Association for Laboratory Animal Science : JAALAS. 59(2): 132-138, 2020. 

20.          Fang C.Y.,Ragin C.C., Addressing disparities in cancer screening among u.S. Immigrants: Progress and opportunities. Cancer Prev Res (Phila). 13(3): 253-260, 2020.PMC7080302.

21.          Feng H., Gusev A., Pasaniuc B., Wu L., Long J., Abu-Full Z., Aittomaki K., Andrulis I.L., Anton-Culver H., Antoniou A.C., Arason A., Arndt V., Aronson K.J., Arun B.K., Asseryanis E., Auer P.L., Azzollini J., Balmana J., Barkardottir R.B., Barnes D.R., Barrowdale D., Beckmann M.W., Behrens S., Benitez J., Bermisheva M., Bialkowska K., Blanco A., Blomqvist C., Boeckx B., Bogdanova N.V., Bojesen S.E., Bolla M.K., Bonanni B., Borg A., Brauch H., Brenner H., Briceno I., Broeks A., Bruning T., Burwinkel B., Cai Q., Caldes T., Caligo M.A., Campbell I., Canisius S., Campa D., Carter B.D., Carter J., Castelao J.E., Chang-Claude J., Chanock S.J., Christiansen H., Chung W.K., Claes K.B.M., Clarke C.L., Couch F.J., Cox A., Cross S.S., Cybulski C., Czene K., Daly M.B., de la Hoya M., De Leeneer K., Dennis J., Devilee P., Diez O., Domchek S.M., Dork T., Dos-Santos-Silva I., Dunning A.M., Dwek M., Eccles D.M., Ejlertsen B., Ellberg C., Engel C., Eriksson M., Fasching P.A., Fletcher O., Flyger H., Fostira F., Friedman E., Fritschi L., Frost D., Gabrielson M., Ganz P.A., Gapstur S.M., Garber J., Garcia-Closas M., Garcia-Saenz J.A., Gaudet M.M., Giles G.G., Glendon G., Godwin A.K., Goldberg M.S., Goldgar D.E., Gonzalez-Neira A., Greene M.H., Gronwald J., Guenel P., Haiman C.A., Hall P., Hamann U., Hake C., He W., Heyworth J., Hogervorst F.B.L., Hollestelle A., Hooning M.J., Hoover R.N., Hopper J.L., Huang G., Hulick P.J., Humphreys K., Imyanitov E.N., Isaacs C., Jakimovska M., Jakubowska A., James P., Janavicius R., Jankowitz R.C., John E.M., Johnson N., Joseph V., Jung A., Karlan B.Y., Khusnutdinova E., Kiiski J.I., Konstantopoulou I., Kristensen V.N., Laitman Y., Lambrechts D., Lazaro C., Leroux D., Leslie G., Lester J., Lesueur F., Lindor N., Lindstrom S., Lo W.Y., Loud J.T., Lubinski J., Makalic E., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Martens J.W.M., Martinez M.E., Matricardi L., Maurer T., Mavroudis D., McGuffog L., Meindl A., Menon U., Michailidou K., Kapoor P.M., Miller A., Montagna M., Moreno F., Moserle L., Mulligan A.M., Muranen T.A., Nathanson K.L., Neuhausen S.L., Nevanlinna H., Nevelsteen I., Nielsen F.C., Nikitina-Zake L., Offit K., Olah E., Olopade O.I., Olsson H., Osorio A., Papp J., Park-Simon T.W., Parsons M.T., Pedersen I.S., Peixoto A., Peterlongo P., Peto J., Pharoah P.D.P., Phillips K.A., Plaseska-Karanfilska D., Poppe B., Pradhan N., Prajzendanc K., Presneau N., Punie K., Pylkas K., Radice P., Rantala J., Rashid M.U., Rennert G., Risch H.A., Robson M., Romero A., Saloustros E., Sandler D.P., Santos C., Sawyer E.J., Schmidt M.K., Schmidt D.F., Schmutzler R.K., Schoemaker M.J., Scott R.J., Sharma P., Shu X.O., Simard J., Singer C.F., Skytte A.B., Soucy P., Southey M.C., Spinelli J.J., Spurdle A.B., Stone J., Swerdlow A.J., Tapper W.J., Taylor J.A., Teixeira M.R., Terry M.B., Teule A., Thomassen M., Thone K., Thull D.L., Tischkowitz M., Toland A.E., Tollenaar R., Torres D., Truong T., Tung N., Vachon C.M., van Asperen C.J., van den Ouweland A.M.W., van Rensburg E.J., Vega A., Viel A., Vieiro-Balo P., Wang Q., Wappenschmidt B., Weinberg C.R., Weitzel J.N., Wendt C., Winqvist R., Yang X.R., Yannoukakos D., Ziogas A., Milne R.L., Easton D.F., Chenevix-Trench G., Zheng W., Kraft P.,Jiang X., Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol, 2020. 

22.          Flaig T.W., Spiess P.E., Agarwal N., Bangs R., Boorjian S.A., Buyyounouski M.K., Chang S., Downs T.M., Efstathiou J.A., Friedlander T., Greenberg R.E., Guru K.A., Guzzo T., Herr H.W., Hoffman-Censits J., Hoimes C., Inman B.A., Jimbo M., Kader A.K., Lele S.M., Michalski J., Montgomery J.S., Nandagopal L., Pagliaro L.C., Pal S.K., Patterson A., Plimack E.R., Pohar K.S., Preston M.A., Sexton W.J., Siefker-Radtke A.O., Tward J., Wright J.L., Gurski L.A.,Johnson-Chilla A., Bladder cancer, version 3.2020, nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 18(3): 329-354, 2020. 

23.          Franco-Barraza J., Raghavan K.S., Luong T.,Cukierman E., Engineering clinically-relevant human fibroblastic cell-derived extracellular matrices. Methods Cell Biol. 156: 109-160, 2020. 

24.          Gauvin G., Yeo C.T., Ungi T., Merchant S., Lasso A., Jabs D., Vaughan T., Rudan J.F., Walker R., Fichtinger G.,Engel C.J., Real-time electromagnetic navigation for breast-conserving surgery using naviknife technology: A matched case-control study. Breast Journal. 26(3): 399-405, 2020. 

25.          Ghatalia P.,Plimack E.R., Integration of immunotherapy into the treatment of advanced urothelial carcinoma. J Natl Compr Canc Netw. 18(3): 355-361, 2020. 

26.          Go C.K., Gross S., Hooper R.,Soboloff J., Egr-mediated control of stim expression and function. Cell Calcium. 77: 58-67, 2019.PMC6467086.

27.          Goldberg D., Doby B., Siminoff L., Shah M.,Lynch R., Rejecting bias: The case against race adjustment for opo performance in communities of color. Am J Transplant, 2020. 

28.          Heald B., Hampel H., Church J., Dudley B., Hall M.J., Mork M.E., Singh A., Stoffel E., Stoll J., You Y.N., Yurgelun M.B.,Kupfer S.S., Collaborative group of the americas on inherited gastrointestinal cancer position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Fam Cancer, 2020. 

29.          Higa J.T.,Irani S.S., Response. Gastrointest Endosc. 91(4): 958-959, 2020. 

30.          Hlubocky F.J., Taylor L.P., Marron J.M., Spence R.A., McGinnis M.M., Brown R.F., McFarland D.C., Tetzlaff E.D., Gallagher C.M., Rosenberg A.R., Popp B., Dragnev K., Bosserman L.D., Dudzinski D.M., Smith S., Chatwal M., Patel M.I., Markham M.J., Levit K., Bruera E., Epstein R.M., Brown M., Back A.L., Shanafelt T.D.,Kamal A.H., A call to action: Ethics committee roundtable recommendations for addressing burnout and moral distress in oncology. JCO Oncol Pract: Jop1900806, 2020. 

31.          Hu S., Alpert L., Goldblum J., Bakhshwin A., Shetty S., Graham R., Wang H.L., Lollie T., Yantiss R., Hissong E., Siddique A., Resnick M., Wu E., Panarelli N., Kuan K., Pomper J., Bellizzi A., Klimstra D., Shia J., Vyas M., Longacre T., Raghavan S., Misdraji J., Kakar S., Choi W.T., Robert M., Li H.J., Feely M., Bronner M., Dong Z., Hosseini M., Hu J.J., Westerhoff M., Cheng J., Cooper H., Nagarathinam R., Agostini-Vulaj D., Gao Z.H., Demko N., Lauwers G., Ghayouri M., Hart J.,Gonzalez R., Gastrointestinal stromal tumors arising in uncommon locations: Clinicopathologic features and risk assessment of esophageal, appendiceal, and colonic tumors. Laboratory Investigation. 100(SUPPL 1): 682-683, 2020. 

32.          Ichkhanian Y., Vosoughi K., Diehl D.L., Grimm I.S., James T.W., Templeton A.W., Hajifathalian K., Tokar J.L., Samarasena J.B., Chehade N.E.H., Lee J., Chang K., Mizrahi M., Barawi M., Irani S., Friedland S., Korc P., Aadam A.A., Al-Haddad M.A., Kowalski T.E., Novikov A., Smallfield G., Ginsberg G.G., Oza V.M., Panuu D., Fukami N., Pohl H., Lajin M., Kumta N.A., Tang S.J., Naga Y.M., Amateau S.K., Brewer G.O.I., Kumbhari V., Sharaiha R.,Khashab M.A., A large multicenter cohort on the use of full-thickness resection device for difficult colonic lesions. Surg Endosc, 2020. 

33.          Iwafuchi M., Cuesta I., Donahue G., Takenaka N., Osipovich A.B., Magnuson M.A., Roder H., Seeholzer S.H., Santisteban P.,Zaret K.S., Gene network transitions in embryos depend upon interactions between a pioneer transcription factor and core histones. Nat Genet, 2020. 

34.          Iyer P., Chen M.H., Goyal L.,Denlinger C.S., Targets for therapy in biliary tract cancers: The new horizon of personalized medicine. Chin Clin Oncol. 9(1): 7, 2020. 

35.          Kaplon A.W., Galloway T.J., Bhayani M.K.,Liu J.C., Effect of hpv status on survival of oropharynx cancer with distant metastasis. Otolaryngol Head Neck Surg: 194599820913604, 2020. 

36.          Khowsathit J., Bazzoli A., Cheng H.,Karanicolas J., Computational design of an allosteric antibody switch by deletion and rescue of a complex structural constellation. ACS Central Science, 2020. 

37.          Krais J.J.,Johnson N., Ectopic rnf168 expression promotes break-induced replication-like DNA synthesis at stalled replication forks. Nucleic Acids Res, 2020. 

38.          Krais J.J., Wang Y., Bernhardy A.J., Clausen E., Miller J.A., Cai K.Q., Scott C.L.,Johnson N., Rnf168-mediated ubiquitin signaling inhibits the viability of brca1 null cancers. Cancer Res, 2020. 

39.          Kutikov A., Weinberg D.S., Edelman M.J., Horwitz E.M., Uzzo R.G.,Fisher R.I., A war on two fronts: Cancer care in the time of covid-19. Ann Intern Med, 2020. 

40.          Lee M., Bhimla A.,Ma G.X., Depressive symptom severity and immigration-related characteristics in asian american immigrants. J Immigr Minor Health, 2020. 

41.          Luo X., Jhala N., Khurana J.S., Fundakowski C., Jhala D.N.,Wang H., Moving toward a systematic approach for reporting salivary gland cytopathology: An institutional experience and literature review. Arch Pathol Lab Med. 143(6): 664-669, 2019. 

42.          Maluchenko N.V., Sultanov D.S., Kotova E.Y., Kirpichnikov M.P., Studitsky V.M.,Feofanov A.V., Histone tails promote parp1-dependent structural rearrangements in nucleosomes. Dokl Biochem Biophys. 489(1): 377-379, 2019. 

43.          Marchioni M., Berardinelli F., Zhang C., Simone G., Uzzo R.G., Capitanio U., Minervini A., Lau C., Kaouk J., Langenstroer P., Amparore D., de Luyk N., Porter J., Gallucci M., Kutikov A., Larcher A., Mari A., Kilday P., Rha K.H., Quarto G., Perdonà S., White W., Eun D.D., Derweesh I., Mottrie A., Anele U.A., Jacobsohn K., Porpiglia F., Challacombe B., Sundaram C.P., Autorino R., Yang B.,Schips L., Effect of obesity and overweight status on complications and survival after minimally invasive kidney surgery in patients with clinical t<inf>2-4</inf> renal masses. Journal of endourology. 34(3): 289-297, 2020. 

44.          Mavaddat N., Antoniou A.C., Mooij T.M., Hooning M.J., Heemskerk-Gerritsen B.A., Noguès C., Gauthier-Villars M., Caron O., Gesta P., Pujol P., Lortholary A., Barrowdale D., Frost D., Evans D.G., Izatt L., Adlard J., Eeles R., Brewer C., Tischkowitz M., Henderson A., Cook J., Eccles D., van Engelen K., Mourits M.J.E., Ausems M.G.E.M., Koppert L.B., Hopper J.L., John E.M., Chung W.K., Andrulis I.L., Daly M.B., Buys S.S., Benitez J., Caldes T., Jakubowska A., Simard J., Singer C.F., Tan Y., Olah E., Navratilova M., Foretova L., Gerdes A.M., Roos-Blom M.J., Van Leeuwen F.E., Arver B., Olsson H., Schmutzler R.K., Engel C., Kast K., Phillips K.A., Terry M.B., Milne R.L., Goldgar D.E., Rookus M.A., Andrieu N.,Easton D.F., Erratum: Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of brca1 and brca2 mutation carriers (breast cancer research : Bcr (2020) 22 1 (8)). Breast cancer research : BCR. 22(1): 25, 2020. 

45.          Melchior N.M., Sachs D.B., Gauvin G., Chang C., Wang C.E., Sigurdson E.R., Daly J.M., Aggon A.A., Hayes S.B., Obeid E.I.,Bleicher R.J., Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy? Cancer Medicine, 2020. 

46.          Michel K.F., Strother M.C., Lee D.J.,Lee D.I., Aso author reflections: Prolonged length of stay after robotic-assisted radical prostatectomy-a separate problem from perioperative complications. Ann Surg Oncol, 2020. 

47.          Minervini A., Campi R., Lane B.R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., Antonelli A., Noyes S., Mari A., Rodriguez-Faba O., Keeley F.X., Langenhuijsen J., Musi G., Klatte T., Roscigno M., Akdogan B., Furlan M., Karakoyunlu N., Marszalek M., Capitanio U., Volpe A., Brookman-May S., Gschwend J.E., Smaldone M.C., Uzzo R.G., Carini M.,Kutikov A., Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: A prospective multicenter study. J Urol. 203(3): 496-504, 2020. 

48.          Minervini A., Campi R., Lane B.R., De Cobelli O., Sanguedolce F., Hatzichristodoulou G., Antonelli A., Noyes S., Mari A., Rodriguez-Faba O., Keeley F.X., Langenhuijsen J., Musi G., Klatte T., Roscigno M., Akdogan B., Furlan M., Karakoyunlu N., Marszalek M., Capitanio U., Volpe A., Brookman-May S., Gschwend J.E., Smaldone M.C., Uzzo R.G., Carini M.,Kutikov A., Reply by authors. The Journal of urology. 203(3): 503-504, 2020. 

49.          Miron B., Hoffman-Censits J.H., Anari F., O’Neill J., Geynisman D.M., Zibelman M.R., Kutikov A., Viterbo R., Greenberg R.E., Chen D., Lallas C.D., Trabulsi E.J., Alpaugh R.K., Dulaimi E., Golemis E.A., Uzzo R., Ross E.A.,Plimack E.R., Defects in DNA repair genes confer improved long-term survival after cisplatin-based neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol Oncol, 2020. 

50.          Mookerjee-Basu J., Hooper R., Gross S., Schultz B., Go C.K., Samakai E., Ladner J., Nicolas E., Tian Y., Zhou B., Zaidi M.R., Tourtellotte W., He S., Zhang Y., Kappes D.J.,Soboloff J., Suppression of ca(2+) signals by egr4 controls th1 differentiation and anti-cancer immunity in vivo. EMBO Rep: e48904, 2020. 

51.          Murthy R.K., Song J., Raghavendra A.S., Li Y., Hsu L., Hess K.R., Barcenas C.H., Valero V., Carlson R.W., Tripathy D.,Hortobagyi G.N., Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice. NPJ Breast Cancer. 6: 11, 2020.PMC7096449.

52.          Nakhoda S.K.,Olszanski A.J., Addressing recent failures in immuno-oncology trials to guide novel immunotherapeutic treatment strategies. Pharmaceut Med. 34(2): 83-91, 2020. 

53.          Nam H., Kundu A., Brinkley G.J., Chandrashekar D.S., Kirkman R.L., Chakravarthi B.V.S.K., Orlandella R.M., Norian L.A., Sonpavde G., Ghatalia P., Fei F., Wei S., Varambally S.,Sudarshan S., Pgc1α suppresses kidney cancer progression by inhibiting collagen-induced snail expression. Matrix Biology, 2020. 

54.          Ozdener M.H., Donadoni M., Cicalese S., Spielman A.I., Garcia-Blanco A., Gordon J.,Sariyer I.K., Zika virus infection in chemosensory cells. J Neurovirol, 2020. 

55.          Reck M., Peters S., Ramalingam S., Paz-Ares L., Caro R.B., Zurawski B., Kim S.W., Alexandru A., Lupinacci L., Jitnenez E.D., Sakai H., Albert I., Vergnenegre A., Borghaei H., Brahmer J.R., O’Byrne K., Geese W.J., Bhagavatheeswaran P., Nattan F.E.,Hellmann M.D., Nivolumab (n) plus low-dose ipilimumab (i) vs platinum-doublet chemotherapy (chemo) as first-line (1l) treatment (tx) for advanced non-small cell lung cancer (nsclc): Checkmate 227 part 1 final analysis. Oncology Research and Treatment. 43: 233-234, 2020. 

56.          Reinacher-Schick A.C., Kindler H.L., Hammel P., Reni M., Van Cutsem E., Mercade T.M., Hall M.J., Park J.O., Hochhauser D., Oh D.Y., Tortora G., Algul H., O’Reilly E.M., McGuinness D., Cui K., Schlienger K., Locker G.Y., Golan T.,Arnold D., Polo: Efficacy and health-related quality of life (hrqol) with maintenance olaparib following first-line platinum-based chemotherapy (pbc) in patients (pts) with a germline brca mutation and metastatic pancreatic cancer (mpc). Oncology Research and Treatment. 43: 68-68, 2020. 

57.          Reyngold M., Winter K.A., Regine W.F., Abrams R.A., Safran H., Hoffman J.P., Mowat R.B., Hayes J.P., Kessel I.L., DiPetrillo T., Narayan S., Chen Y., Ben-Josef E., Delouya G., Suh J.H., Meyer J., Haddock M.G., Feldman M., Gaur R., Yost K., Peterson R.A., Sherr D.L., Moughan J.,Crane C.H., Marital status and overall survival in patients with resectable pancreatic cancer: Results of an ancillary analysis of nrg oncology/rtog 9704. Oncologist. 25(3): e477-e483, 2020.PMC7066692.

58.          Riddle D.L., Slover J., Keefe F.J., Ang D.C., Dumenci L.,Perera R.A., Racial differences in pain and function following knee arthroplasty: A secondary analysis from a multicenter randomized clinical trial. Arthritis Care Res (Hoboken), 2020. 

59.          Rogers B.B., B-cell malignancies: The use of small molecule agents for treatment and management. Clin J Oncol Nurs. 24(2): 199-204, 2020. 

60.          Sigg D., Voelz V.A.,Carnevale V., Microcanonical coarse-graining of the kinetic ising model. J Chem Phys. 152(8): 084104, 2020.PMC7042020.

61.          Spirko-Burns L.,Devarajan K., Unified methods for feature selection in large-scale genomic studies with censored survival outcomes. Bioinformatics, 2020. 

62.          Steffen L.E., Cheavens J.S., Vowles K.E., Gabbard J., Nguyen H., Gan G.N., Edelman M.J.,Smith B.W., Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patients. Support Care Cancer. 28(2): 827-835, 2020.PMC6885110.

63.          Su H., Sravanam S., Gorantla S., Kaminski R., Khalili K., Poluektova L., Gendelman H.E.,Dash P.K., Amplification of replication competent hiv-1 by adoptive transfer of human cells from infected humanized mice. Front Cell Infect Microbiol. 10: 38, 2020.PMC7026001.

64.          Tao Q., Barba-Montoya J., Huuki L.A., Durnan M.K.,Kumar S., Relative efficiencies of simple and complex substitution models in estimating divergence times in phylogenomics. Mol Biol Evol, 2020. 

65.          Teras J., Kroon H.M., Miura J.T., Kenyon-Smith T., Beasley G.M., Mullen D., Farrow N.E., Mosca P.J., Lowe M.C., Farley C.R., Potdar A., Daou H., Sun J., Carr M., Farma J.M., Henderson M.A., Speakman D., Serpell J., Delman K.A., Smithers B.M., Barbour A., Tyler D.S., Coventry B.J., Zager J.S.,Thompson J.F., International multicenter experience of isolated limb infusion for in-transit melanoma metastases in octogenarian and nonagenarian patients. Ann Surg Oncol, 2020. 

66.          Testa J.R.,Berns A., Preclinical models of malignant mesothelioma. Front Oncol. 10: 101, 2020.PMC7026500.

67.          Thompson J.A., Schneider B.J., Brahmer J., Andrews S., Armand P., Bhatia S., Budde L.E., Costa L., Davies M., Dunnington D., Ernstoff M.S., Frigault M., Kaffenberger B.H., Lunning M., McGettigan S., McPherson J., Mohindra N.A., Naidoo J., Olszanski A.J., Oluwole O., Patel S.P., Pennell N., Reddy S., Ryder M., Santomasso B., Shofer S., Sosman J.A., Wang Y., Weight R.M., Johnson-Chilla A., Zuccarino-Catania G.,Engh A., Nccn guidelines insights: Management of immunotherapy-related toxicities, version 1.2020. J Natl Compr Canc Netw. 18(3): 230-241, 2020. 

68.          Vijayvergia N., Dasari A., Deng M., Litwin S., Al-Toubah T., Alpaugh R.K., Dotan E., Hall M.J., Ross N.M., Runyen M.M., Denlinger C.S., Halperin D.M., Cohen S.J., Engstrom P.F.,Strosberg J.R., Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: Joint analysis of two prospective, non-randomised trials. Br J Cancer, 2020. 

69.          Vogel A., Sahai V., Hollebecque A., Vaccaro G., Melisi D., Al-Rajabi R., Paulson A.S., Borad M.J., Gallinson D., Murphy A.G., Oh D.Y., Dotan E., Catenacci D., Van Cutsem E., Lihou C., Zhen H.L., Feliz L.,Abou-Alfa G., Fight-202: A phase 2 study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (cca). Oncology Research and Treatment. 43: 220-221, 2020. 

70.          Williams A.D., Bleicher R.J.,Ciocca R.M., Breast cancer risk, screening, and prevalence among sexual minority women: An analysis of the national health interview survey. LGBT Health. 7(2): 109-118, 2020. 

71.          Winn J.S., Hasse Z., Slifker M., Pei J., Arisi-Fernandez S.M., Talarchek J.N., Obeid E., Baldwin D.A., Gong Y., Ross E., Cristofanilli M., Alpaugh R.K.,Fernandez S.V., Genetic variants detected using cell-free DNA from blood and tumor samples in patients with inflammatory breast cancer. International Journal of Molecular Sciences. 21(4)2020.PMC7072950.

72.          Wong V.,Geynisman D.M., Incidentally discovered primary mediastinal germ cell tumor. Jaapa. 33(4): 35-37, 2020. 

73.          Yao K., Bleicher R., Moran M., Chang C., Dietz J., Stearns V., Connolly J., Sarantou T.,Kurtzman S., Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (cpm): A survey of physicians from accredited breast centers in the united states. Cancer Med, 2020. 

74.          Zaladonis A., Zhang X., Manupipatpong K.K., Kalaiselvan S., Alvarez P.,Jensen L.E., Interleukin-36 (il-36) system in the 1-fluoro-2,4-dinitrobenzene (dnfb) mouse model of allergic contact dermatitis. Allergy, 2020. 

75.          Zhang Z., Liu S., Zhang B., Qiao L., Zhang Y.,Zhang Y., T cell dysfunction and exhaustion in cancer. Front Cell Dev Biol. 8: 17, 2020.PMC7027373.

76.          Zhang Y.W., Nasto R.E., Jablonski S.A., Serebriiskii I.G., Surana R., Murray J., Johnson M., Riggins R.B., Clarke R., Golemis E.A.,Weiner L.M., Rna interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods Enzymol. 636: 299-322, 2020. 

77.          Zhang Y., Gordon S.M., Xi H., Choi S., Paz M.A., Sun R., Yang W., Saredy J., Khan M., Remaley A.T., Wang J.F., Yang X.,Wang H., Hdl subclass proteomic analysis and functional implication of protein dynamic change during hdl maturation. Redox Biol. 24: 101222, 2019.PMC6541906.

78.          Zhang T., Yin C., Boyd D.F., Quarato G., Ingram J.P., Shubina M., Ragan K.B., Ishizuka T., Crawford J.C., Tummers B., Rodriguez D.A., Xue J., Peri S., Kaiser W.J., Lopez C.B., Xu Y., Upton J.W., Thomas P.G., Green D.R.,Balachandran S., Influenza virus z-rnas induce zbp1-mediated necroptosis. Cell. 180(6): 1115-1129.e13, 2020. 

79.          Zhao S., Song T., Gu Y., Zhang Y., Cao S., Miao Q., Zhang X., Chen H., Gao Y., Zhang L., Han Y., Wang H., Pu J., Xie L.,Ji Y., Hydrogen sulfide alleviates liver injury via s-sulfhydrated-keap1/nrf2/lrp1 pathway. Hepatology, 2020. 

Predatory Journals

Learn how to protect yourself.

Predatory journals are often referred to as the dark side of academic publishing and it is easy to see why.  These journals and their publishers seek to exploit unsuspecting authors by tricking them into making submissions to their disreputable journals.  Shining a light on these practices and educating authors to the dangers of predatory publishing is one way to ensure that the scholarly community is not scammed or exploited by these publications.

For this Talbot Topic we will dig a little in the world of predatory journals, publishing and conferences.  We will also share some resources the library has created that you can use to avoid being a victim of these insidious publishing practices.

Predatory publishers often use elaborate scamming techniques such as cloning and hijacking academic journals or society websites, claiming false impact factors or accreditations, and creating nonexistent editorial boards packed with high profile scientists.  These journals will aggressively solicit articles with false claims of immediate peer review, low submission fees, and guaranteed acceptances.

You can protect yourself by being aware of these techniques and doing some research to learn more about the journals you are considering publishing in, the conferences you may be interested in presenting at, and the offers you get for editorial boards and peer reviewing.  Knowing the warning signs and red flags can help you avoid a potential problem with predatory publishing that could affect your academic reputation.

The Talbot Library has a subject guide on Scholarly Communications with a section on predatory journals that can help educate and protect you during the publication process.  The guide has information on identifying a predatory journal, publisher, or conference.  Resources for learning more about predatory journals and ways to protect your work can be found there as well.  You can also learn how to identify a predatory email solicitation.

The guide also has the tools you will need to research journals, learn about impact factors, and reliable information on assessing the quality of open access publishers.  You will also find links to the organizations that work to ensure the quality of open source journals. 

The guide has a great video on avoiding predatory journals and infographics that can be shared with your colleagues to help shine a light on the dark side of academic publishing.

Learning how to identify a predatory journals and taking steps to protect yourself from being a victim of a predatory publisher will help to safeguard your academic reputation and ensure your research is available at reputable sources for the long term.  If you need help assessing the value of journal, please reach out to the librarians at the Talbot Library for help.

The Scholarly Communication Guide

Predatory Journals

The Resources for Post Docs Guide (How to Get Published)